Pfeiffer Christine M, Looker Anne C
National Center for Environmental Health and
National Center for Health Statistics, Centers for Disease Control and Prevention, Atlanta, GA.
Am J Clin Nutr. 2017 Dec;106(Suppl 6):1606S-1614S. doi: 10.3945/ajcn.117.155887. Epub 2017 Oct 25.
Biochemical assessment of iron status relies on serum-based indicators, such as serum ferritin (SF), transferrin saturation, and soluble transferrin receptor (sTfR), as well as erythrocyte protoporphyrin. These indicators present challenges for clinical practice and national nutrition surveys, and often iron status interpretation is based on the combination of several indicators. The diagnosis of iron deficiency (ID) through SF concentration, the most commonly used indicator, is complicated by concomitant inflammation. sTfR concentration is an indicator of functional ID that is not an acute-phase reactant, but challenges in its interpretation arise because of the lack of assay standardization, common reference ranges, and common cutoffs. It is unclear which indicators are best suited to assess excess iron status. The value of hepcidin, non-transferrin-bound iron, and reticulocyte indexes is being explored in research settings. Serum-based indicators are generally measured on fully automated clinical analyzers available in most hospitals. Although international reference materials have been available for years, the standardization of immunoassays is complicated by the heterogeneity of antibodies used and the absence of physicochemical reference methods to establish "true" concentrations. From 1988 to 2006, the assessment of iron status in NHANES was based on the multi-indicator ferritin model. However, the model did not indicate the severity of ID and produced categorical estimates. More recently, iron status assessment in NHANES has used the total body iron stores (TBI) model, in which the log ratio of sTfR to SF is assessed. Together, sTfR and SF concentrations cover the full range of iron status. The TBI model better predicts the absence of bone marrow iron than SF concentration alone, and TBI can be analyzed as a continuous variable. Additional consideration of methodologies, interpretation of indicators, and analytic standardization is important for further improvements in iron status assessment.
铁状态的生化评估依赖于基于血清的指标,如血清铁蛋白(SF)、转铁蛋白饱和度、可溶性转铁蛋白受体(sTfR)以及红细胞原卟啉。这些指标给临床实践和国家营养调查带来了挑战,而且铁状态的解读通常基于多种指标的综合判断。通过SF浓度(最常用的指标)诊断缺铁(ID)会因并发炎症而变得复杂。sTfR浓度是功能性ID的一个指标,它不是急性期反应物,但由于缺乏检测标准化、通用参考范围和通用临界值,其解读存在挑战。目前尚不清楚哪些指标最适合评估铁过量状态。铁调素、非转铁蛋白结合铁和网织红细胞指数的价值正在研究中探索。基于血清的指标一般在大多数医院都有的全自动临床分析仪上进行检测。尽管国际参考物质已经存在多年,但免疫分析的标准化因所用抗体的异质性以及缺乏用于确定“真实”浓度的物理化学参考方法而变得复杂。1988年至2006年,美国国家健康与营养检查调查(NHANES)中铁状态的评估基于多指标铁蛋白模型。然而,该模型并未表明ID的严重程度,且产生的是分类估计值。最近,NHANES中铁状态评估采用了全身铁储存(TBI)模型,其中评估了sTfR与SF的对数比值。sTfR和SF浓度共同涵盖了铁状态的整个范围。TBI模型比单独的SF浓度能更好地预测骨髓铁缺乏情况,并且TBI可以作为一个连续变量进行分析。进一步改进铁状态评估时,对方法学另外的考量、指标解读和分析标准化很重要。